ProKidney (PROK) News Today → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free PROK Stock Alerts $4.05 +0.26 (+6.86%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 1:31 PM | insidertrades.comProKidney Corp. (NASDAQ:PROK) Insider Buys $19,600.00 in StockMay 16, 2024 | marketbeat.comControl Empresarial De Capital Buys 14,000 Shares of ProKidney Corp. (NASDAQ:PROK) StockProKidney Corp. (NASDAQ:PROK - Get Free Report) insider Control Empresarial De Capital acquired 14,000 shares of the firm's stock in a transaction on Friday, March 22nd. The stock was purchased at an average price of $1.40 per share, with a total value of $19,600.00. Following the purchase, the insider now owns 63,265,645 shares in the company, valued at approximately $88,571,903. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.May 16, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 4.1% ProKidney (NASDAQ:PROK) Trading Down 4.1%May 15, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Down to $4.12ProKidney (NASDAQ:PROK) Shares Gap Down to $4.12May 14, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Up 9.4%ProKidney (NASDAQ:PROK) Stock Price Up 9.4%May 13, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Up to $2.81ProKidney (NASDAQ:PROK) Shares Gap Up to $2.81May 11, 2024 | finance.yahoo.comWe're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash WiselyMay 10, 2024 | finance.yahoo.comProKidney Corp Reports First Quarter 2024 Financial ResultsMay 10, 2024 | investorplace.comPROK Stock Earnings: ProKidney Beats EPS for Q1 2024May 10, 2024 | globenewswire.comProKidney Reports Business Updates and First Quarter 2024 Financial ResultsMay 7, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Trading Up 5.8%ProKidney (NASDAQ:PROK) Trading 5.8% HigherApril 29, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Up 6.1%ProKidney (NASDAQ:PROK) Stock Price Up 6.1%April 28, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) Sees Large Drop in Short InterestProKidney Corp. (NASDAQ:PROK - Get Free Report) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 11,560,000 shares, a drop of 17.3% from the March 31st total of 13,980,000 shares. Based on an average daily volume of 702,200 shares, the short-interest ratio is presently 16.5 days. Currently, 26.7% of the company's stock are sold short.April 26, 2024 | finance.yahoo.comDiabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2032April 25, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Stock Price Down 7.4%ProKidney (NASDAQ:PROK) Shares Down 7.4%April 24, 2024 | insidertrades.comInsider Selling: ProKidney Corp. (NASDAQ:PROK) SVP Sells 16,438 Shares of StockApril 22, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Sees Large Volume IncreaseProKidney (NASDAQ:PROK) Sees Strong Trading VolumeApril 20, 2024 | finance.yahoo.comPROK Apr 2024 5.000 putApril 19, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Down 2.5% ProKidney (NASDAQ:PROK) Trading Down 2.5%April 19, 2024 | insidertrades.comDarin J. Weber Sells 17,238 Shares of ProKidney Corp. (NASDAQ:PROK) StockApril 18, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Down Following Insider SellingProKidney (NASDAQ:PROK) Shares Gap Down on Insider SellingApril 17, 2024 | marketbeat.comProKidney Corp. (NASDAQ:PROK) SVP Darin J. Weber Sells 17,238 SharesProKidney Corp. (NASDAQ:PROK - Get Free Report) SVP Darin J. Weber sold 17,238 shares of ProKidney stock in a transaction that occurred on Tuesday, April 16th. The stock was sold at an average price of $2.50, for a total value of $43,095.00. Following the transaction, the senior vice president now owns 172,432 shares of the company's stock, valued at $431,080. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.April 17, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Shares Gap Up to $2.72ProKidney (NASDAQ:PROK) Shares Gap Up to $2.72March 26, 2024 | bizjournals.comDuring manufacturing pause, ProKidney increases R&D spending to $106.7MMarch 25, 2024 | globenewswire.comProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical OperationsMarch 24, 2024 | markets.businessinsider.comBuy Rating Affirmed for ProKidney Amidst Strategic Clinical Advancements and Solid Financial OutlookMarch 21, 2024 | globenewswire.comProKidney Reports Full Year 2023 Financial Results and Recent Corporate HighlightsMarch 21, 2024 | marketbeat.comProKidney (PROK) to Release Earnings on FridayProKidney (NASDAQ:PROK) will be releasing earnings on Friday, March 22, Yahoo Finance reports.March 7, 2024 | realmoney.thestreet.comProKidney assumed with an Equal Weight at Morgan StanleyMarch 7, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Earns Equal Weight Rating from Morgan StanleyMorgan Stanley reaffirmed an "equal weight" rating and set a $3.00 price target on shares of ProKidney in a research report on Thursday.March 3, 2024 | marketbeat.comProKidney (PROK) Set to Announce Earnings on MondayProKidney (NASDAQ:PROK) will be releasing earnings on Monday, March 4, Yahoo Finance reports.February 29, 2024 | globenewswire.comProKidney to Participate in Jefferies Biotech on the Bay SummitFebruary 17, 2024 | finance.yahoo.comPROK Mar 2024 7.500 callFebruary 16, 2024 | bizjournals.comNorth Carolina biotech tops $400M in funding for asthma treatmentFebruary 9, 2024 | fool.comProKidney (NASDAQ: PROK)January 10, 2024 | marketbeat.comSocial Capital Group LLC Sells 1,700,000 Shares of ProKidney Corp. (NASDAQ:PROK)Social Capital Group LLC cut its position in shares of ProKidney Corp. (NASDAQ:PROK - Free Report) by 12.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,573,000 shares of the company's stock after selling 1,700,000 shares during the quarJanuary 3, 2024 | markets.businessinsider.comBTIG Reaffirms Their Buy Rating on ProKidney (PROK)January 2, 2024 | marketbeat.comProKidney (NASDAQ:PROK) Downgraded by Bank of AmericaBank of America downgraded ProKidney from a "buy" rating to a "neutral" rating in a research report on Tuesday.December 28, 2023 | bizjournals.comStories to Watch in 2024: Leadership changes, manufacturing pause make 2024 critical year for ProKidneyDecember 16, 2023 | ca.finance.yahoo.comPROK Jan 2024 10.000 callDecember 13, 2023 | finance.yahoo.comHere's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock NowNovember 30, 2023 | bizjournals.comProKidney makes two changes to C-suite, terminating long-serving COO and promoting from within for chief business officerNovember 30, 2023 | finance.yahoo.comProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business OfficerNovember 21, 2023 | msn.comProKidney former 10% owner Chamath Palihapitiya discloses sale of over 7M sharesNovember 21, 2023 | finance.yahoo.comProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx ConferenceNovember 17, 2023 | finance.yahoo.comProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call TranscriptNovember 17, 2023 | finance.yahoo.comCompanies Like ProKidney (NASDAQ:PROK) Are In A Position To Invest In GrowthNovember 16, 2023 | finance.yahoo.comAfter Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)November 16, 2023 | markets.businessinsider.comProKidney’s Future Promising: REACT Trial Success and Strategic Enrollment Shift Boosts Buy RatingNovember 15, 2023 | msn.comProKidney pauses manufacturing after audit, company says Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now PROK Media Mentions By Week PROK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PROK News Sentiment▼0.920.42▲Average Medical News Sentiment PROK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PROK Articles This Week▼101▲PROK Articles Average Week Get ProKidney News Delivered to You Automatically Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMTX News RLAY News AUTL News MESO News PRME News BCRX News RGNX News CRGX News SRRK News HUMA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PROK) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
